American Academy of Neurology, 2015 Annual Meeting: Advisor’s Introduction.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. i, doi. 10.1177/1559897715589100
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2015 AND VI 15 AND IP 9
Results: 22
1
2
Clinical Issues: Migraine Biomarkers, BP and Recurrent ICH, and Autism Genetics.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 26, doi. 10.1177/1559897715589085
- By:
- Publication type:
- Article
3
Disease Activity in Year 1 Predicts Long-term Outcomes in Patients Taking Fingolimod.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 17, doi. 10.1177/1559897715589077
- By:
- Publication type:
- Article
4
Applying Genetic Discoveries to the Treatment of PD and Epilepsy.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 29, doi. 10.1177/1559897715588747
- By:
- Publication type:
- Article
5
AAN Transforms Neurologist Challenges Into Opportunities for Improvement.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 2, doi. 10.1177/1559897715588746
- By:
- Publication type:
- Article
6
Neurologic Emergencies Require Rapid Plan of Action.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 20, doi. 10.1177/1559897715588494
- By:
- Publication type:
- Article
7
REFLEXION Trial: Delayed Treatment of First MS Event Increases Time to CDMS.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 14, doi. 10.1177/1559897715588491
- By:
- Publication type:
- Article
8
Idebenone Delays Respiratory Decline in Duchenne Muscular Dystrophy.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 6, doi. 10.1177/1559897715588490
- By:
- Publication type:
- Article
9
DECIDE: Daclizumab HYP Superior to IFN-β-1a for Brain Lesion Activity in RRMS.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 19, doi. 10.1177/1559897715588476
- By:
- Publication type:
- Article
10
Baseline Features of Patients With RMS in Ocrelizumab Trials OPERA I and OPERA II.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 14, doi. 10.1177/1559897715588475
- By:
- Publication type:
- Article
11
MODERATO Study to Assess the Effect of Rasagiline on Patients With Parkinson Disease and Mild Cognitive Impairment.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 9, doi. 10.1177/1559897715588474
- By:
- Publication type:
- Article
12
Sleep Disorder Challenges, Diagnosis, and Treatments: Hypersomnolence and OSA.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 23, doi. 10.1177/1559897715588464
- By:
- Publication type:
- Article
13
Teriflunomide Associated With Reductions in Severe MS Relapses.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 17, doi. 10.1177/1559897715588463
- By:
- Publication type:
- Article
14
MR CLEAN: Endovascular Therapy Improves Outcomes in Acute Ischemic Stroke.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 7, doi. 10.1177/1559897715588318
- By:
- Publication type:
- Article
15
Depression and Antiepileptic Drug Use Do Not Affect Eslicarbazepine Efficacy in Patients With Partial-Onset Seizures.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 10, doi. 10.1177/1559897715588297
- By:
- Publication type:
- Article
16
Levodopa-Carbidopa Intestinal Gel Shows Promise in Advanced Parkinson Disease.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 11, doi. 10.1177/1559897715588296
- By:
- Publication type:
- Article
17
A2NTX an Effective Substitute for OnabotulinumtoxinA in Poststroke Spasticity.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 13, doi. 10.1177/1559897715588291
- By:
- Publication type:
- Article
18
The Changing Landscape of Epilepsy.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 4, doi. 10.1177/1559897715588290
- By:
- Publication type:
- Article
19
Brivaracetam Reduces Seizure Frequency in Patients With Partial-Onset Seizures.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 11, doi. 10.1177/1559897715588284
- By:
- Publication type:
- Article
20
AVP-825 Produces Effective, Well-Tolerated Migraine Relief.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 8, doi. 10.1177/1559897715588283
- By:
- Publication type:
- Article
21
EXPEDITION EXT: Delayed-Start Analyses of Solanezumab in Patients With Mild AD.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 15, doi. 10.1177/1559897715588277
- By:
- Publication type:
- Article
22
TARGET: Nasal Delivery of Sumatriptan Powder Improves Functioning in Patients With Migraine.
- Published in:
- MD Conference Express, 2015, v. 15, n. 9, p. 7, doi. 10.1177/1559897715588276
- By:
- Publication type:
- Article